- In April 2024, Eko Health, a leading innovator in digital health, received FDA clearance for its AI-powered algorithm capable of detecting signs of heart failure (low ejection fraction) during routine physical exams using its smart stethoscope. This collaboration with the Mayo Clinic represents a major advancement in integrating artificial intelligence into non-invasive, point-of-care diagnostics, significantly enhancing clinical decision-making in primary care settings
- In February 2025, Lapsi Health launched the Keikku Smart Stethoscope, an FDA-approved wireless device equipped with Bluetooth Low Energy (LE), LED indicators, and high-fidelity audio streaming. Designed to support telemedicine and remote diagnostics, the Keikku is expected to revolutionize clinical workflows by offering real-time connectivity and cloud-based auscultation tools
- In October 2024, researchers from Imperial College London conducted a groundbreaking study on over 1,000 patients using Eko’s AI-powered stethoscope to predict Major Adverse Cardiac Events (MACE). The findings demonstrated the potential of smart stethoscopes as effective tools for early cardiovascular risk detection in both clinical and remote settings
- In April 2025, a team of scientists at the University of Cambridge unveiled a multi-sensor smart stethoscope designed to detect early signs of heart valve disease, even through clothing. The device, which uses machine learning to analyze sounds and vibrations, has shown high accuracy and is expected to improve early intervention and preventive care for cardiovascular conditions
